CAMBRIDGE, Mass., Sept. 3 (HSMN NewsFeed) -- Satori Pharmaceuticals Incorporated, a privately held developer of therapeutics for Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders, today announced that Steven Holtzman, CEO an... Biopharmaceuticals, Neurology, PersonnelSatori Pharmaceuticals (Source: HSMN NewsFeed)

Read the original Alzheimer's Group Resources article at MedWorm: Alzheimer's ...

Tags: , , ,

Leave your comment


SEO Powered by Platinum SEO from Techblissonline